Trial intelligence / Profile preview

Ketamine plus propofol dosing in hysteroscopic surgery

ChiCTR2400079740Phase 4Not yet recruiting

Sponsor
Pinggu District Hospital
Start
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ketamine and propofol in hysteroscopic surgery (4 arms), sponsored by Pinggu District Hospital. Primary endpoint: Incidence of ambulatory salvage propofol. Planned start Jan 2024; status: not yet recruiting.

02

Drugs

ketaminepropofol
03

Conditions

hysteroscopic surgery

Beyond the preview

Go deeper on ChiCTR2400079740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400079740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call